Advertisement

Topics

U.S. Stem Cell, Inc. Company Profile

04:26 EDT 21st October 2018 | BioPortfolio

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.


News Articles [2337 Associated News Articles listed on BioPortfolio]

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Collaboration aims to enhance stem cell selection, expansion

Cellect Biotherapeutics and South Korean biotech Cell2in will collaborate on improving stem cell quality used for stem cell t -More- 

Media Advisory: The New York Stem Cell Foundation Conference

(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF)'s 13th annual translational stem cell research conference convenes global leaders in stem cell research to present their lates...

Investing in Stem Cell Treatments

Stem cell treatments have grabbed investor attention for years, but can be be complex and a dangerous treatment. Here is an overview of investing in stem cell treatments. The post Investing in Stem Ce...

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA appr...

International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal

CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage bio...

FDA Moves to Shutter Stem Cell Clinics

The FDA recently filed complaints in federal court seeking “permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviati...

Scientists discover a mechanism through which HIV determines the fate and function of cells

A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell t...

PubMed Articles [4874 Associated PubMed Articles listed on BioPortfolio]

Orchestrating Ribosomal Subunit Coordination to Control Stem Cell Fate.

The mechanisms responsible for maintaining ribosomal component stoichiometry, which is critical during cell fate transitions, are currently not well understood. In this issue of Cell Stem Cell, Corsin...

Muscling in on the Awesome Proliferative Power of the Terrible Teratoma.

In this issue of Cell Stem Cell, Chan et al. (2018) report that in vivo differentiation of pluripotent stem cells in induced teratomas produces functional embryonic-like muscle stem cells. These pur...

Intestinal Stem Cell Dynamics: A Story of Mice and Humans.

Stem cell dynamics define the probability of accumulating mutations within the intestinal epithelium. In this issue of Cell Stem Cell, Nicholson et al. (2018) report that human intestinal stem cell d...

Women in Stem Cell Science: Part I.

Female scientists play important leadership roles in the field and with the International Society for Stem Cell Research. We asked a number of these top researchers to share their personal stories and...

Systemic delivery of mesenchymal stem cells condition media in repeated doses acts as magic bullets in restoring IFN-γ/IL-4 balance in asthmatic rats.

With respect to recent advantage in stem cell application, given the concern reported previously after stem cell transplantation, mesenchymal stem cell-derived conditioned media (MSC-CM) could be a po...

Clinical Trials [7791 Associated Clinical Trials listed on BioPortfolio]

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of ...

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

The purpose of this study is to find out if getting a blood stem cell transplant with donor stem cells given over several days is better than getting a blood stem cell transplant with dono...

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is compari...

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune ...

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a...

Companies [1085 Associated Companies listed on BioPortfolio]

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

National Stem Cell Foundation

The National Stem Cell Foundation (NSCF) is a charitable 501(c)3 organization that funds adult stem cell and regenerative medicine research to accelerate treatment options, advoca...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

The New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF, ...

International Society for Stem Cell Research

The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of informati...

More Information about "U.S. Stem Cell, Inc." on BioPortfolio

We have published hundreds of U.S. Stem Cell, Inc. news stories on BioPortfolio along with dozens of U.S. Stem Cell, Inc. Clinical Trials and PubMed Articles about U.S. Stem Cell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of U.S. Stem Cell, Inc. Companies in our database. You can also find out about relevant U.S. Stem Cell, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...


Corporate Database Quicklinks



Searches Linking to this Company Record